Table 6

Percentage of apoptotic HT29 cells after third schedule administration as identified by three different techniques

TreatmentSub-G1 peakPI supravital exposureMorphology
0 h24 ha0 h24 h0 h24 h
Control0.6b0.6111.61
1 nm TAX00.601NDcND
5 nm TAX0202NDND
10 nm TAX08010ND5
3 × 2 Gy557633
1 nm + 3 × 2 Gy96116NDND
5 nm + 3 × 2 Gy138127NDND
10 nm + 3 × 2 Gy22152010158
Sodium azide, 0.1%000000
Dexamethasone, 100 nm8ND7ND6ND
  • a 24 h drug-free medium.

  • b Data represent mean values from three separate experiments; SD, <5%.

  • c ND, not determined.